abstract |
The present invention relates to compounds of formula (1) that bind to the NR1 H4 receptor (FXR) and act as agonists of FXR. The present invention also relates to the use of said compounds for the manufacture of medicaments for the treatment of diseases and/or disorders by binding said compounds to said nuclear receptors, and to methods of synthesizing said compounds. |